剖析肺纤维化相关的肺高血压的肺转录组
Adam J Brownstein1, Marco Mura2, Gregoire Ruffenach3
1Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, California, United States.
概括
这项研究揭示了肺纤维化 (PF-PH) 和肺动脉高血压 (PAH) 中的肺高血压之间的共享基因表达模式. 确定关键的基因模块为PF-PH提供了潜在的治疗点.
科学领域:
- 基因组学就是基因组学.
- 系统生物学 系统生物学
- 肺部医学 肺部医学
背景情况:
- 肺纤维化 (PF) 可以导致肺高血压 (PF-PH),这是一个复杂的疾病,需要更好地了解其病理生理学.
- 综合性多组学方法对于阐明PF-PH背后的分子机制至关重要.
- 确定PF-PH和肺动脉高血压 (PAH) 之间的共同分子通路可能会揭示新的治疗策略.
研究的目的:
- 通过加权基因联合表达网络分析 (WGCNA) 来研究PF-PH患者肺组织的转录基因格局.
- 识别与肺血管抵抗 (PVR) 相关的基因模块,并将其与血液动力学数据相关联.
- 为了比较PF-PH和独立的PAH队列之间的基因表达特征,以发现共享的分子特征.
主要方法:
- 通过PVR分层,WGCNA被应用于116个解释的PF肺部的转录组数据.
- 进行了差异基因表达分析和模块特征与血液动力学参数的相关性.
- 基因模块在独立的PAH肺转录组学签名中进行了丰富测试;进行了药物转录组学分析.
主要成果:
- 在PF-PH中,在高和低PVR组之间确定了1,250个差异表达的基因.
- 特定的基因模块 (棕色和深灰色) 与PVR正相关,并表现出与PAH特征的丰富.
- 药物转录组分析表明色和深灰色模块的致病作用,特雷普罗斯尼尔显示负连接性和BMP功能丧失显示正连接性.
结论:
- 综合性分析确定了与PF-PH疾病严重程度相关的关键基因模块.
- 证实了PF-PH和PAH之间共享的基因表达模式,突出了共同的致病机制.
- 鉴定到的模块和基因标需要进一步研究,以开发针对PF-PH的新疗法.
相关概念视频
01:30Pulmonary Hypertension: Classification and Pathogenesis
906
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
906
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40